Published Oct 6, 2022

Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Join Andy Acker as he delves into the high-stakes world of biotech investing, uncovering the transformative power of scientific innovations and gene-based therapies, while navigating the complex landscape of healthcare investments and overlooked market opportunities.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Answers 383 questions
Rod Wong – Empty Rooms: Innovation in Biotech at RTW (Capital Allocators, EP. 310)
Answers 383 questions
Andy Lee – Empty Rooms: Investing in Tax Assets at Parallaxes Capital (Capital Allocators, EP.305)
Answers 383 questions
Rodrigo Bitar – Empty Rooms: Investing in Venezuela (Capital Allocators, EP.268)
Answers 383 questions
Kiyan Zandiyeh – Empty Rooms: Venture Capital on the Emerging Frontier at Sturgeon Capital (Capital Allocators, EP.317)
Answers 383 questions
Colin Smith and Farouk Miah - Empty Rooms: Investing in Africa (Capital Allocators, EP. 279)
Answers 383 questions
Chris Dixon - Empty Rooms: Web3 After the Fall (EP.380)
Answers 383 questions
Ted Martell – Empty Rooms: Commercial Real Estate Non-Performing Loans in NYC at Maverick Real Estate (EP.349)
Answers 383 questions
Jon Harris – Investing in People at AIM (Capital Allocators, EP.105)
Answers 383 questions
Thomas Majewski – Empty Rooms: Masterclass on CLOs at Eagle Point Credit Management (Capital Allocators, EP. 284)
Answers 383 questions
Deep Dive into Hedge Funds (Capital Allocators, EP.34)
Answers 383 questions
André Perold – Pockets of Inefficiency at HighVista Strategies (Capital Allocators, EP.169)
Answers 383 questions
Andy Redleaf - Evolution of Markets (Capital Allocators, EP.46)
Answers 383 questions
Jason Klein – Investing to Cure Cancer (Capital Allocators, EP.28)
Answers 383 questions
Dan Ariely – Investing in Irrationality (Capital Allocators, EP.93)
Answers 383 questions

Dexa/Capital Allocators – Inside the Institutional Investment Industry

Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Topics covered

Popular Clips

Drug Trial Dynamics

Unmet Medical Needs

Navigating Biotech Investments

Biotech Market Dynamics

Healthcare Investment Strategies

Portfolio Decision-Making

Precision Medicine Advances

Launching New Therapies

Biotech Market Dynamics

Breakthrough Therapies

Biotech Breakthroughs

Biotech Market Recovery

Investing Journey Insights

Investment Insights Unveiled

Episode Highlights

Scientific Innovations

Healthcare Investment Strategies

Biotech Market Dynamics

Related Episodes

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Rod Wong – Empty Rooms: Innovation in Biotech at RTW (Capital Allocators, EP. 310)

Andy Lee – Empty Rooms: Investing in Tax Assets at Parallaxes Capital (Capital Allocators, EP.305)

Rodrigo Bitar – Empty Rooms: Investing in Venezuela (Capital Allocators, EP.268)

Kiyan Zandiyeh – Empty Rooms: Venture Capital on the Emerging Frontier at Sturgeon Capital (Capital Allocators, EP.317)

Colin Smith and Farouk Miah - Empty Rooms: Investing in Africa (Capital Allocators, EP. 279)

Chris Dixon - Empty Rooms: Web3 After the Fall (EP.380)

Ted Martell – Empty Rooms: Commercial Real Estate Non-Performing Loans in NYC at Maverick Real Estate (EP.349)

Jon Harris – Investing in People at AIM (Capital Allocators, EP.105)

Thomas Majewski – Empty Rooms: Masterclass on CLOs at Eagle Point Credit Management (Capital Allocators, EP. 284)

Deep Dive into Hedge Funds (Capital Allocators, EP.34)

André Perold – Pockets of Inefficiency at HighVista Strategies (Capital Allocators, EP.169)

Andy Redleaf - Evolution of Markets (Capital Allocators, EP.46)

Jason Klein – Investing to Cure Cancer (Capital Allocators, EP.28)

Dan Ariely – Investing in Irrationality (Capital Allocators, EP.93)

Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Topics covered

Popular Clips

Episode Highlights

Scientific InnovationsAndy Acker explores the transformative potential of breakthrough therapies and gene-based innovations in the biotech sector. He discusses the challenges and opportunities within drug trials, highlighting the high-risk, high-reward nature of investing in this field.

Scientific Innovations

Healthcare Investment StrategiesAndy Acker discusses the intricacies of healthcare portfolio management, highlighting the balance between stability and innovation. He emphasizes the importance of risk management and the pivotal role of management teams in driving investment success.

Healthcare Investment Strategies

Biotech Market DynamicsAndy Acker, Portfolio Manager at Janus Henderson Investors, explores the volatile yet promising biotech sector. He discusses market dynamics, signs of recovery, and unique investment opportunities often overlooked by mainstream investors.

Biotech Market Dynamics

Related Episodes